Use of Noninvasive Imaging in Cardiac Amyloidosis

Raymundo Alain Quintana-Quezada, Syed Wamique Yusuf, Jose Banchs

Research output: Contribution to journalReview article

1 Scopus citations


Cardiac involvement in amyloidosis is associated with poor outcomes. The standard test for the diagnosis of cardiac amyloidosis is endomyocardial biopsy but given current advances in noninvasive imaging, the diagnosis is frequently obtained or strongly suspected without biopsy. Echocardiography is the most utilized cardiac imaging modality, particularly myocardial strain measures with this modality have been found to be a predictor of clinical outcomes, superior to traditional parameters. Other known imaging modalities with new, useful protocols for this pathology include nuclear imaging and cardiac magnetic resonance (CMR). In particular, CMR has excellent sensitivity and specificity.

Original languageEnglish (US)
Article number46
JournalCurrent Treatment Options in Cardiovascular Medicine
Issue number7
StatePublished - Jul 1 2016



  • Cardiac amyloidosis
  • Cardiac magnetic resonance
  • Cardio-oncology
  • Endomyocardial biopsy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this